Same plant, same glands, two molecules that differ only in the position of a single atom. And yet: one is regulated by law, the other is not.
This tiny difference explains the entire legal market—its purpose, its thresholds, and some of its excesses.
We’ve been growing and processing since 2020, between the Moroccan Rif and Switzerland. Here’s what really sets these two molecules apart, how it affects what you’re buying, and why the legal threshold is more nuanced than a simple percentage.
Each batch is tested in a Swiss laboratory, with the total THC content explicitly stated. Full spectrum, with no isolates or synthetic molecules —the profile is that of the plant, not that of a formula.
THC and CBD share exactly the same molecular formula. They have the same number of carbon, hydrogen, and oxygen atoms. What differs is their arrangement: THC forms a closed ring, while CBD leaves its ring open.
This subtle difference is enough to alter how each molecule binds to the body’s receptors. THC binds effectively, while CBD does so much less so. This explains the psychoactive effect of one and the absence of such an effect in the other.
It is therefore not a matter of dose or purity. Highly concentrated CBD never becomes psychoactive —the molecule simply doesn’t have the key to the lock.
Hemp and so-called recreational cannabis are the same botanical species. What sets them apart is the result of varietal selection driven in opposite directions.
A plant has a limited amount of the precursor—CBG—and directs it toward one molecule or the other depending on its genetics . Producing a lot of CBD automatically means producing little THC. This isn’t a treatment applied to the plant; it’s simply what the plant is.
The role of this precursor molecule is detailed in our article on CBG and its regulatory use.
This is the most useful point in this article—and the most misunderstood.
The plant does not produce THC directly: it produces THCA, its acidic form. THCA converts to THC when exposed to heat or over time.
Consequence: An analysis that reports only THC underestimates the product’s actual content. The authoritative figure is “total THC, ” which adds up the THC that has already formed and the converted THCA.
This leads to a situation that many retailers discover too late: a product may show a reassuring THC level but exceed the threshold for total THC. Always check this line, not the other one.
Thresholds also vary from country to country, as do the methods used to calculate them. The complete comparison can be found in our article on the differences between Switzerland, France, and the European Union.
Let’s move beyond the chemistry, because that’s where the real question lies.
What’s the same: the appearance, the smell, the texture, the process, the ritual. Good CBD resin looks just like what you’re used to, because it’s the same process applied to the same plant.
What’s different: the absence of a psychoactive effect. No altered perception, no “high.”
This is precisely what appeals to some consumers: enjoying the substance and the moment, without the high. We’ve dedicated an entire article to this topic— what CBD resin really changes —because it deserves more than just a paragraph.
In this area, caution is not the same as hesitation.
What is documented: THC is psychoactive; CBD is not. CBD is being researched for several indications, some of which have led to approved medications—at dosages far beyond those typically used.
What is not established: most of the benefits attributed to CBD in the marketplace. Sleep, anxiety, pain: the data exist, but they are preliminary and do not support any specific claims.
We sell resin and flowers, not a medication. Details of what has been established can be found in our article on what the research really shows.
In recent years, a third category has slipped in between the two: molecules obtained through chemical processing, sold as “cousins” of CBD.
They are neither CBD nor THC, nor are they produced by the plant. Their only connection to hemp is the name on the packaging, and their sole purpose is to stay one step ahead of the law.
This is now the main danger in the legal market, and we’re dedicating an entire article to it: what’s being sold as CBD in 2026.
The first point alone is enough to rule out most problematic products. It’s also the one that the fewest sellers highlight.
A compliant product contains a trace amount of THC. Depending on the test’s sensitivity and how often you use it, a positive result is still possible —it’s the THC that’s detected, not the CBD.
It’s more concentrated, not more psychoactive. CBD has no psychoactive effects regardless of the dose, and a high CBD content can easily be achieved by adding isolate.
Yes, botanically speaking. The distinction is regulatory and varietal, based on the THC content produced, not on a difference in species.
Because the plant always produces a small amount. A full-spectrum product with absolutely no trace of THC does not exist —if it’s advertised as having zero THC, it’s an isolate or a processed product.
